Skip to content

40 million people now living with HIV

JAMA editorial endorses later treatment

South African mother & baby treatment case begins

Atazanavir: effect on lipids arouses interest

Patents deal may benefit few

Tipranavir development plans announced

Call for access to cheaper monitoring

Hep C combinations show promise in HIV/HCV patients

TRIPS patent agreement: final text